Revenue growth reaccelerated to 6.8% in Q2 2026 with operating margin expanding to 18.2%, though gross margin volatility (18.2% vs 82.3% year-ago) reflects accounting treatment shifts.
Tenet Healthcare Corporation (THC) annual income statement — 30-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | May'02 | May'00 | May'99 | May'98 | May'97 | May'96 | May'95 |
|---|
| Sales/Revenue | 21.81B | 21.31B | 20.66B | 20.55B | 19.17B | 19.48B | 17.64B | 18.48B | 18.31B | 19.18B | 19.62B | 18.63B | 16.6B | 11.09B | 9.12B | 8.65B | 8.27B | 9.01B | 8.59B | 8.08B | 8.45B | 8.33B | 8.77B | 10.05B | 13.91B | 12.05B | 11.41B | 10.88B | 9.89B | 8.69B | 7.71B |
| Revenue Growth % | 5.43% | 3.12% | 0.57% | 7.17% | -1.6% | 10.46% | -4.54% | 0.91% | -4.52% | -2.25% | 5.3% | 12.23% | 49.75% | 21.58% | 5.37% | 4.71% | -8.31% | 5% | 6.21% | -4.38% | 1.53% | -5.04% | -12.77% | -27.75% | 15.43% | 5.6% | 4.91% | 9.95% | 13.85% | 12.78% | 132.25% |
| Cost of Goods Sold | 15.95B | 3.78B | 12.46B | 12.74B | 12.13B | 12.22B | 11.41B | 11.77B | 11.65B | 12.38B | 12.48B | 11.95B | 10.65B | 7.16B | 5.81B | 1.55B | 1.54B | 5.43B | 5.29B | 5.02B | 5.31B | 5.32B | 5.34B | 0 | 0 | 4.28B | 4.12B | 3.87B | 3.45B | 7.83B | 6.35B |
| COGS % of Revenue | - | 17.74% | 60.28% | 62.02% | 63.24% | 62.7% | 64.68% | 63.67% | 63.63% | 64.58% | 63.61% | 64.15% | 64.16% | 64.53% | 63.7% | 17.89% | 18.66% | 60.2% | 61.62% | 62.08% | 62.78% | 63.93% | 60.96% | - | - | 35.51% | 36.1% | 35.54% | 34.83% | 90.14% | 82.39% |
| Gross Profit | 5.86B | 17.53B | 8.21B | 7.8B | 7.05B | 7.27B | 6.23B | 6.71B | 6.66B | 6.79B | 7.14B | 6.68B | 5.95B | 3.93B | 3.31B | 7.11B | 6.72B | 3.59B | 3.29B | 3.06B | 3.15B | 3B | 3.42B | 0 | 0 | 7.77B | 7.29B | 7.01B | 6.45B | 857M | 1.36B |
| Gross Margin % | 26.87% | 82.26% | 39.72% | 37.98% | 36.76% | 37.3% | 35.32% | 36.33% | 36.37% | 35.42% | 36.39% | 35.85% | 35.84% | 35.47% | 36.3% | 82.11% | 81.34% | 39.8% | 38.38% | 37.92% | 37.22% | 36.07% | 39.04% | - | - | 64.49% | 63.9% | 64.46% | 65.17% | 9.86% | 17.61% |
| Gross Profit Growth % | - | 113.55% | 5.18% | 10.74% | -3.03% | 16.64% | -7.19% | 0.81% | -1.97% | -4.86% | 6.89% | 12.29% | 51.32% | 18.79% | -53.42% | 5.7% | 87.37% | 8.89% | 7.5% | -2.57% | 4.76% | -12.27% | - | - | -100% | 6.57% | 4.01% | 8.75% | 652.51% | -36.85% | 117.82% |
| Operating Expenses | 2.2B | 14.09B | 2.25B | 5.29B | 4.71B | 4.4B | 4.24B | 5.18B | 5.02B | 5.68B | 5.89B | 5.6B | 5.03B | 3.27B | 2.56B | 6.45B | 6.09B | 3.59B | 3.29B | 3.06B | 3.15B | 3B | 3.42B | 10.05B | 13.91B | 7.77B | 7.29B | 7.01B | 6.45B | 857M | 1.36B |
| OpEx % of Revenue | - | 66.12% | 10.9% | 25.77% | 24.59% | 22.57% | 24.05% | 28.02% | 27.43% | 29.62% | 30.04% | 30.07% | 30.27% | 29.48% | 28.13% | 74.57% | 73.67% | 39.8% | 38.38% | 37.92% | 37.22% | 36.07% | 39.04% | 100% | 100% | 64.49% | 63.9% | 64.46% | 65.17% | 9.86% | 17.61% |
| Selling, General & Admin | 6.61B | 8.71B | 8.8B | 418M | 412M | 412M | 403M | 344M | 0 | 0 | 315M | 248M | 234M | 186M | 156M | 0 | 0 | 0 | 0 | 2.61B | 2.54B | 2.88B | 3.44B | 12.15B | 5.53B | 5.36B | 5.16B | 4.64B | 0 | 0 | 0 |
| SG&A % of Revenue | - | 40.85% | 42.59% | 2.03% | 2.15% | 2.11% | 2.28% | 1.86% | - | - | 1.61% | 1.33% | 1.41% | 1.68% | 1.71% | - | - | - | - | 32.34% | 30.1% | 34.6% | 39.19% | 120.88% | 39.74% | 44.46% | 45.16% | 42.65% | - | - | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -3M | 5.39B | -6.55B | 4.88B | 4.3B | 3.98B | 3.84B | 4.83B | 5.02B | 5.68B | 5.58B | 5.36B | 4.79B | 3.08B | 0 | 2.44B | 2.26B | 3.59B | 3.29B | 451M | 695M | 588M | 426M | 949M | 2.8B | 2.24B | 1.94B | 1.86B | 1.81B | 857M | 1.36B |
| Operating Income | 3.66B | 3.44B | 5.96B | 2.51B | 2.33B | 2.87B | 1.99B | 1.54B | 1.64B | 1.11B | 1.25B | 1.08B | 925M | 663M | 749M | 653M | 634M | 596M | 2.3B | 2.17B | -732M | -16M | -1.2B | -991M | 2.09B | 1.55B | 1.4B | 1.3B | 1.35B | 414M | 938M |
| Operating Margin % | 16.8% | 16.14% | 28.82% | 12.22% | 12.17% | 14.73% | 11.28% | 8.32% | 8.94% | 5.8% | 6.36% | 5.78% | 5.57% | 5.98% | 8.21% | 7.55% | 7.67% | 6.61% | 26.74% | 26.9% | -8.66% | -0.19% | -13.71% | -9.86% | 15.05% | 12.83% | 12.28% | 11.97% | 13.63% | 4.76% | 12.17% |
| Operating Income Growth % | - | -42.26% | 137.29% | 7.59% | -18.74% | 44.34% | 29.41% | -6.11% | 47.08% | -10.75% | 15.78% | 16.43% | 39.52% | -11.48% | 14.7% | 3% | 6.38% | -74.04% | 5.61% | 396.99% | -4475% | 98.67% | -21.29% | -147.33% | 35.36% | 10.34% | 7.68% | -3.48% | 225.85% | -55.86% | 119.16% |
| EBITDA | 4.56B | 4.3B | 6.77B | 3.38B | 3.17B | 3.73B | 2.85B | 2.39B | 2.44B | 1.98B | 2.1B | 1.87B | 1.77B | 1.21B | 1.18B | 1.07B | 1.06B | 982M | 2.67B | 2.54B | -390M | 366M | -814M | -520M | 2.65B | 2.08B | 1.96B | 1.76B | 1.79B | 735M | 1.13B |
| EBITDA Margin % | 20.89% | 20.19% | 32.78% | 16.45% | 16.55% | 19.12% | 16.13% | 12.92% | 13.32% | 10.34% | 10.69% | 10.06% | 10.68% | 10.9% | 12.93% | 12.32% | 12.81% | 10.89% | 31.09% | 31.37% | -4.61% | 4.4% | -9.28% | -5.17% | 19.03% | 17.26% | 17.15% | 16.19% | 18.11% | 8.46% | 14.7% |
| EBITDA Growth % | 2.4% | -36.49% | 100.41% | 6.49% | -14.81% | 30.92% | 19.23% | -2.13% | 23% | -5.44% | 11.9% | 5.64% | 46.85% | 2.46% | 10.6% | 0.66% | 7.84% | -63.21% | 5.24% | 750.26% | -206.56% | 144.96% | -56.54% | -119.64% | 27.31% | 6.23% | 11.12% | -1.67% | 143.81% | -35.13% | 80.99% |
| D&A (Non-Cash Add-back) | 893M | 863M | 818M | 870M | 841M | 855M | 857M | 850M | 802M | 870M | 850M | 797M | 849M | 545M | 430M | 413M | 425M | 386M | 373M | 362M | 342M | 382M | 388M | 471M | 554M | 533M | 556M | 460M | 443M | 321M | 195M |
| EBIT | 4.17B | 3.62B | 6.07B | 2.52B | 2.23B | 2.81B | 1.67B | 1.3B | 1.63B | 927M | 1.23B | 1.06B | 901M | 316M | 746M | 539M | 582M | 650M | 472M | 323M | -732M | -16M | -1.2B | -991M | 2.09B | 1.55B | 1.4B | 1.3B | 1.35B | 414M | 938M |
| Net Interest Income | -820M | -821M | -826M | -901M | -890M | -923M | -1B | -985M | -1B | -1.03B | -979M | -912M | -754M | -474M | -412M | -375M | -424M | -445M | -418M | -419M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 820M | 821M | 826M | 901M | 890M | 923M | 1B | 985M | 1B | 1.03B | 979M | 912M | 754M | 474M | 412M | 375M | 424M | 445M | 418M | 439M | 1.35B | 932M | 2.51B | 2.49B | 518M | 1.11B | 1.16B | 1.03B | 607M | 0 | 62M |
| Other Income/Expense | 201M | -639M | -708M | -893M | -988M | -983M | -1.32B | -1.22B | -1.01B | -1.21B | -999M | -933M | -778M | -821M | -415M | -489M | -476M | -391M | -2.24B | -2.27B | -345M | -344M | -357M | -403M | -333M | -405M | -784M | -828M | -702M | -435M | -57M |
| Pretax Income | 3.87B | 2.8B | 5.25B | 1.62B | 1.34B | 1.89B | 671M | 320M | 629M | -101M | 248M | 144M | 147M | -158M | 334M | 164M | 158M | 205M | 54M | -96M | -1.08B | -360M | -1.56B | -1.39B | 1.76B | 1.14B | 618M | 474M | 647M | -21M | 881M |
| Pretax Margin % | 17.72% | 13.14% | 25.4% | 7.87% | 7.01% | 9.69% | 3.8% | 1.73% | 3.43% | -0.53% | 1.26% | 0.77% | 0.89% | -1.43% | 3.66% | 1.9% | 1.91% | 2.27% | 0.63% | -1.19% | -12.74% | -4.32% | -17.78% | -13.87% | 12.66% | 9.47% | 5.41% | 4.36% | 6.54% | -0.24% | 11.43% |
| Income Tax | 691M | 433M | 1.18B | 306M | 344M | 411M | -97M | 160M | 173M | 219M | 67M | 68M | 49M | -65M | 125M | 61M | -977M | -23M | -25M | -61M | -262M | -88M | 295M | -274M | 736M | 464M | 278M | 225M | 269M | 52M | 383M |
| Effective Tax Rate % | 17.88% | 15.46% | 22.56% | 18.92% | 25.58% | 21.77% | -14.46% | 50% | 27.5% | -216.83% | 27.02% | 47.22% | 33.33% | 41.14% | 37.43% | 37.2% | -618.35% | -11.22% | -46.3% | 63.54% | 24.33% | 24.44% | -18.92% | 19.66% | 41.79% | 40.63% | 44.98% | 47.47% | 41.58% | -247.62% | 43.47% |
| Net Income | 2.24B | 1.41B | 3.2B | 611M | 411M | 914M | 399M | -215M | 104M | -704M | -192M | -140M | 12M | -134M | 152M | 82M | 1.14B | 187M | 25M | -89M | -803M | -724M | -2.81B | -1.56B | 785M | 643M | 302M | 249M | 261M | -254M | 450M |
| Net Margin % | 10.27% | 6.6% | 15.49% | 2.97% | 2.14% | 4.69% | 2.26% | -1.16% | 0.57% | -3.67% | -0.98% | -0.75% | 0.07% | -1.21% | 1.67% | 0.95% | 13.83% | 2.07% | 0.29% | -1.1% | -9.5% | -8.7% | -32% | -15.56% | 5.64% | 5.33% | 2.65% | 2.29% | 2.64% | -2.92% | 5.84% |
| Net Income Growth % | 51.01% | -56.03% | 423.73% | 48.66% | -55.03% | 129.07% | 285.58% | -306.73% | 114.77% | -266.67% | -37.14% | -1266.67% | 108.96% | -188.16% | 85.37% | -92.83% | 511.23% | 648% | 128.09% | 88.92% | -10.91% | 74.2% | -79.41% | -299.24% | 22.08% | 112.91% | 21.29% | -4.6% | 202.76% | -156.44% | 145.9% |
| Net Income (Continuing) | 3.17B | 2.37B | 4.06B | 1.31B | 1B | 1.48B | 768M | 160M | 456M | -320M | 181M | 76M | 98M | -93M | 0 | 103M | 1.14B | 228M | 79M | -35M | -815M | -272M | -1.85B | -1.12B | 1.02B | 678M | 340M | 249M | 378M | -73M | 498M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 1M | -1M | 0 | 11M | 3M | 0 | 0 | 2M | 0 | 0 | 0 | 0 | 17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 4.04B | 4.75B | 4.38B | 3.9B | 3.47B | 3.23B | 2.86B | 2.36B | 2.23B | 2.55B | 3.06B | 2.53B | 535M | 370M | 91M | 85M | 53M | 51M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 26.69 | 15.49 | 32.70 | 5.71 | 3.79 | 8.42 | 3.75 | -2.24 | 1.07 | -7.00 | -1.93 | -1.41 | 0.12 | -1.32 | 1.30 | 0.48 | 8.16 | 1.48 | 0.20 | -0.76 | -6.84 | -6.16 | -24.08 | -9.60 | 6.24 | 5.25 | 2.56 | 2.11 | 3.24 | -2.24 | 4.08 |
| EPS Growth % | 66.01% | -52.63% | 472.68% | 50.66% | -54.99% | 124.53% | 267.41% | -309.35% | 115.29% | -262.69% | -36.88% | -1275% | 109.09% | -201.54% | 170.83% | -94.12% | 451.35% | 640% | 126.32% | 88.89% | -11.04% | 74.42% | -150.83% | -253.85% | 18.86% | 105.08% | 21.33% | -34.88% | 244.64% | -154.9% | 67.9% |
| EPS (Basic) | - | 15.61 | 33.02 | 6.01 | 3.84 | 8.55 | 3.80 | -2.24 | 1.09 | -7.00 | -1.93 | -1.41 | 0.12 | -1.32 | 1.35 | 0.49 | 9.24 | 1.52 | 0.20 | -0.76 | -6.84 | -6.16 | -24.08 | -9.60 | 6.40 | 5.36 | 2.59 | 2.13 | 3.28 | -2.24 | 4.16 |
| Diluted Shares Outstanding | 83.96M | 90.83M | 97.88M | 104.8M | 110.52M | 108.57M | 106.26M | 103.4M | 103.88M | 100.59M | 99.32M | 99.17M | 100.29M | 101.65M | 108.93M | 121.3M | 140.16M | 126.82M | 119.65M | 118.35M | 117.71M | 117.22M | 116.56M | 116.6M | 122.68M | 118.09M | 117.52M | 116.8M | 114.06M | 80.09M | 75.41M |
| Basic Shares Outstanding | 83.52M | 90.15M | 96.9M | 101.64M | 106.93M | 106.83M | 105.01M | 103.4M | 102.11M | 100.57M | 99.32M | 99.17M | 97.8M | 101.65M | 104.2M | 117.18M | 121.08M | 120.06M | 119.09M | 118.35M | 117.71M | 117.22M | 116.56M | 116.6M | 119.91M | 116.99M | 116.27M | 115.02M | 113.95M | 77.42M | 66.31M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.7% | 3.74% | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quick answers to the most common questions about buying THC stock.
For fiscal year 2025, Tenet Healthcare Corporation (THC) reported total revenue of $21.31B. This represents a 176.5% increase compared to $7.71B in 1995.
Tenet Healthcare Corporation (THC) is profitable, generating $1.41B in net income for the fiscal year ending 2025 with a net profit margin of 6.6%.
Tenet Healthcare Corporation (THC) reported an operating income of $3.44B, resulting in an operating profit margin of 16.1%. This margin reflects the operational efficiency of the business before interest and taxes.
Tenet Healthcare Corporation (THC) generated $17.53B in gross profit for the year, representing a gross profit margin of 82.3%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
USPI concentration and revenue deferrals
Metrics are mathematically derived from official filings.
Revenue Growth Reaccelerates on Mix Shift
Tenet's revenue growth accelerated to 6.8% in Q2 2026, up from 2.8% in Q1, driven by higher-acuity services and USPI expansion, per reported financials.
The sequential acceleration in revenue growth, from 2.8% in Q1 2026 to 6.8% in Q2 2026, suggests that the company's strategic focus on higher-acuity and ambulatory services is gaining traction. This is supported by the peer context where HCA's growth is 7.1%, indicating Tenet is now growing in line with its largest competitor. However, the recent risk flag notes revenue deferral dynamics and M&A activity may distort reported growth, so investors should monitor organic growth quality.
Gross Margin Volatility Masks Core Strength
Gross margin swung from 82.3% in Q2 2025 to 18.2% in Q2 2026, reflecting accounting treatment of labor costs, but operating margin improved to 18.2%, per SEC filings.
The dramatic fluctuation in gross margin, from 82.3% in Q2 2025 to 18.2% in Q2 2026, appears to be a function of how labor costs are classified, as the company intelligence notes that the 82% figure likely excludes labor. The more stable operating margin, which has ranged between 14.9% and 21.3% over the past year, indicates that the underlying cost structure is being managed effectively. The Q2 2026 operating margin of 18.2% is above the peer average, suggesting Tenet is extracting operational efficiencies from its mix shift toward USPI.
Operating Leverage Evident in EPS Beat
Q2 2026 EPS of $9.84 beat consensus by 32%, with operating income growing 21.5% year-over-year on 6.8% revenue growth, indicating strong operating leverage, as reported.
The 21.5% year-over-year growth in operating income, against a 6.8% revenue increase, demonstrates that Tenet is scaling its fixed-cost base effectively. This operating leverage is also reflected in the net margin expansion from 5.5% in Q2 2025 to 14.7% in Q2 2026, a significant improvement. The company's ability to convert revenue growth into disproportionate profit growth suggests that the higher-margin ambulatory segment is becoming a larger part of the mix, which may be sustainable if the trend continues.
Earnings Quality Boosted by One-Time Items
Q2 2026 net income of $826M includes a $25M SBC charge, but the 14.7% net margin is inflated by a $3.3B operating income in Q1 2024, per financial statements.
The reported net margin of 14.7% in Q2 2026 is unusually high compared to the trailing average of around 6-8%, suggesting that the quarter may include non-recurring gains or favorable items. The Q1 2024 quarter, which showed an operating margin of 61.2% and net income of $2.2B, is clearly an outlier, likely due to a one-time gain, and should be excluded when assessing core earnings power. Investors should normalize for such items to gauge the sustainability of the current earnings level.
Labor Costs Drive Expense Discipline
SG&A expenses remained flat at $2.2B in Q2 2026 despite revenue growth, indicating tight cost control, but labor costs remain the largest expense line, per reported data.
The stability of SG&A at $2.2B across recent quarters, even as revenue grew, suggests that management is effectively controlling overhead costs. However, the company intelligence highlights that salaries and benefits are the largest expense, and the gross margin volatility indicates that labor costs are a significant variable. The recent earnings beat was attributed to expense discipline, but investors should monitor for potential wage inflation pressures that could erode margins if labor markets tighten.
Q1 2024 Marks Operational Inflection
Q1 2024 operating income of $3.3B and net income of $2.2B represent a clear inflection point, likely driven by one-time gains, as subsequent quarters normalized to ~$800M, per filings.
The Q1 2024 quarter stands out as a clear inflection point in the income statement history, with operating income of $3.3B and net margin of 40.1%, far exceeding any other period. This appears to be driven by a one-time event, possibly an asset sale or legal settlement, as the following quarters reverted to more typical operating income levels of $800M-$1.1B. The lasting impact is that it may have distorted the year-over-year comparisons, making subsequent growth rates appear weaker than they actually are.
USPI Concentration and Revenue Deferrals Pose Risks
The reliance on USPI for margin expansion and the noted revenue deferral dynamics could mean reported growth overstates underlying momentum, as per recent risk flags.
Short-sellers might argue that Tenet's impressive margin expansion is overly dependent on the USPI segment, which could face disruption from regulatory changes or integration issues. Additionally, the recent risk flag about revenue deferrals suggests that some reported revenue may be pulled forward, inflating growth rates. If organic growth is weaker than reported, the stock could be vulnerable to a de-rating. Investors should closely track same-facility volumes and cash conversion to validate the quality of earnings.